vimarsana.com

Page 87 - பெங்கல் தலைமை அமைச்சர் மாமத பானர்ஜி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Coronavirus Updates: Johnson & Johnson seeks permission to conduct phase 3 trials in India: Report

Coronavirus Updates: Johnson & Johnson seeks permission to conduct phase 3 trials in India: Report Firstpost 2 hours ago FP Staff © Provided by Firstpost Coronavirus Updates: Johnson & Johnson seeks permission to conduct phase 3 trials in India: Report 23:36 (IST) Johnson & Johnson seeks permission for phase-3 trial in India Multinational pharma giant Johnson & Johnson has applied to India s drug regulator seeking permission to conduct phase-3 clinical trial of its single-dose COVID-19 vaccine in India as well as import licence, PTI reported. They said the company has sought an early meeting of the subject expert committee on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) to take a decision on its application.

Bengal: EC Imposes 24-hour Campaign Ban on BJP s Sayantan Basu, TMC s Sujata Mondal

Bengal: EC Imposes 24-hour Campaign Ban on BJP s Sayantan Basu, TMC s Sujata Mondal The bar on campaigning by the leaders will be in force from 7 pm on April 18 to 7 pm on April 19. Representative image of TMC and BJP supporters. Photo: PTI/Reuters Politics7 hours ago New Delhi: The Election Commission on Sunday imposed a 24-hour campaign ban on BJP leader Sayantan Basu and Sujata Mondal of the Trinamool Congress for their controversial remarks during the ongoing assembly polls in West Bengal. The bar on campaigning by the leaders will be in force from 7 pm on April 18 to 7 pm on April 19.

Coronavirus LIVE Updates: Johnson & Johnson seeks permission to conduct phase 3 trials in India: Report

Coronavirus Updates: Johnson & Johnson seeks permission to conduct phase 3 trials in India: Report Firstpost 2 hours ago FP Staff © Provided by Firstpost Coronavirus Updates: Johnson & Johnson seeks permission to conduct phase 3 trials in India: Report 23:36 (IST) Johnson & Johnson seeks permission for phase-3 trial in India Multinational pharma giant Johnson & Johnson has applied to India s drug regulator seeking permission to conduct phase-3 clinical trial of its single-dose COVID-19 vaccine in India as well as import licence, PTI reported. They said the company has sought an early meeting of the subject expert committee on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) to take a decision on its application.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.